Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Max Moldovan

4PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsEvolutionary ecologyNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Aug 07, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.

Lisa M Butler, Chui Yan Mah, Jelle Machiels

|Jul 17, 2020
Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.

Zeyad D Nassar, Chui Yan Mah, Margaret M Centenera

|May 28, 2020
National Trends in Antibiotic Use in Australian Residential Aged Care Facilities, 2005-2016.

Janet K Sluggett, Max Moldovan, David J Lynn

|Apr 10, 2018
Frailty index from routine laboratory measurements correlates with leukocyte telomere length.

Elsa Dent, Emiel O Hoogendijk, Max Moldovan

Pageof 1

Frequent Collaborators

2 joint publications

Zeyad D Nassar

2 joint publications

Chui Yan Mah

2 joint publications

David J Lynn

2 joint publications

Lisa M Butler

1 joint publications

Elsa Dent

1 joint publications

Emiel O Hoogendijk

1 joint publications

Janet K Sluggett

1 joint publications

Martin C Sadowski

1 joint publications

Julia S Scott

1 joint publications

Roger J Daly

Frequent Collaborators

2 joint publications

Zeyad D Nassar

2 joint publications

Chui Yan Mah

2 joint publications

David J Lynn

2 joint publications

Lisa M Butler

Top Related Videos

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on : Aug 02, 2018

12.4K
<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.1K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on : Aug 30, 2018

13.3K
See more related videos

Top Related Videos

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on : Aug 02, 2018

12.4K
<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

<em>Ex Vivo</em> Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on : Oct 02, 2014

15.1K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on : Aug 30, 2018

13.3K
See more related videos